Kenalog-10 and Anaphylaxis - a phase IV clinical study of FDA data

Summary:

Anaphylaxis is reported as a side effect among people who take Kenalog-10 (triamcinolone acetonide), especially for people who are female, 20-29 old, also take Kenalog-40, and have Acne.

The phase IV clinical study analyzes which people have Anaphylaxis when taking Kenalog-10. It is created by eHealthMe based on reports of 391 people who have side effects when taking Kenalog-10 from the FDA, and is updated regularly.

What is Kenalog-10?

Kenalog-10 has active ingredients of triamcinolone acetonide. eHealthMe is studying from 401 Kenalog-10 users. Check the latest studies of Kenalog-10.

What is Anaphylaxis?

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death) is found to be associated with 1,934 drugs and 2,859 conditions by eHealthMe. Check the latest studies of Anaphylaxis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

391 people reported to have side effects when taking Kenalog-10.
Among them, 17 people (4.35%) have Anaphylaxis.

Could Kenalog-10 cause Anaphylaxis?

Among these 17 people:

What is the gender of people who have Anaphylaxis when taking Kenalog-10? *

  • female: 53.33 %
  • male: 46.67 %

What is the age of people who have Anaphylaxis when taking Kenalog-10? *

  • 0-1: 0.0 %
  • 2-9: 10 %
  • 10-19: 10 %
  • 20-29: 30 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 20 %
  • 60+: 10 %

What are other drugs people take besides Kenalog-10? *

  1. Prednisone: 1 person, 5.88%
  2. Lidocaine: 1 person, 5.88%
  3. Kenalog-40: 1 person, 5.88%

What are other side effects people have besides Anaphylaxis? *

  1. Nausea (feeling of having an urge to vomit): 2 people, 11.76%
  2. Hypotension (abnormally low blood pressure): 2 people, 11.76%
  3. Weakness: 1 person, 5.88%
  4. Insomnia (sleeplessness): 1 person, 5.88%
  5. Confusion: 1 person, 5.88%
  6. Drug Hypersensitivity: 1 person, 5.88%
  7. Face Oedema (swelling of face): 1 person, 5.88%
  8. Headache (pain in head): 1 person, 5.88%
  9. High Blood Pressure: 1 person, 5.88%
  10. Ill-Defined Disorder: 1 person, 5.88%

What are the existing conditions these people have? *

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.88%
  2. Alopecia Areata (patchy baldness that typically begins with rapid hair loss): 1 person, 5.88%
  3. Acne (skin problems that cause pimples): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog-10 and have Anaphylaxis?

- Check whether Anaphylaxis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kenalog-10:

Anaphylaxis treatments and more:

How severe was Anaphylaxis and when was it recovered:

Expand to all the drugs that have ingredients of triamcinolone acetonide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kenalog-10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anaphylaxis:

Browse all the conditions that are associated with Anaphylaxis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Kenalog-10) and Kenalog-10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: